Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

900. Goedert JJ, Cote TR, Virgo P, Scoppa
SM, Kingma DW, Gail MH, Jaffe ES,
Biggar RJ (1998). Spectrum of AIDS-associated
malignant disorders. Lancet 351:
1833-1839.
901. Goessl C, Knispel HH, Miller K, Klan R
(1997). Is routine excretory urography
necessary at first diagnosis of bladder
cancer? J Urol 157: 480-481.
902. Gold PJ, Fefer A, Thompson JA
(1996). Paraneoplastic manifestations of
renal cell carcinoma. Semin Urol Oncol
14: 216-222.
903. Goldblum JR, Lloyd RV (1993).
Primary renal carcinoid. Case report and
literature review. Arch Pathol Lab Med
117: 855-858.
904. Golde DW, Schambelan M,
Weintraub BD, Rosen SW (1974).
Gonadotropin-secreting renal carcinoma.
Cancer 33: 1048-1053.
905. Goldgar DE, Easton DF, Cannon-
Albright LA, Skolnick MH (1994).
Systematic population-based assessment
of cancer risk in first-degree relatives
of cancer probands. J Natl Cancer
Inst 86: 1600-1608.
906. Goldstein NS (2002). Immunophenotypic
characterization of 225
prostate adenocarcinomas with intermediate
or high Gleason scores. Am J Clin
Pathol 117: 471-477.
907. Golub TR, Slonim DK, Tamayo P,
Huard C, Gaasenbeek M, Mesirov JP,
Coller H, Loh ML, Downing JR, Caligiuri
MA, Bloomfield CD, Lander ES (1999).
Molecular classification of cancer: class
discovery and class prediction by gene
expression monitoring. Science 286: 531-
537.
908. Goluboff ET, O’Toole K, Sawczuk IS
(1994). Leiomyoma of bladder: report of
case and review of literature. Urology 43:
238-241.
909. Gomez CA, Soloway MS, Civantos F,
Hachiya T (1993). Bladder neck preservation
and its impact on positive surgical
margins during radical prostatectomy.
Urology 42: 689-693.
910. Gomez MR (1999). Definition and criteria
for diagnosis. In: Tuberous Sclerosis
Complex, MR Gomez, ed. Oxford
University Press: Oxford, pp. 10-23.
911. Gondos B (1993). Ultrastructure of
developing and malignant germ cells. Eur
Urol 23: 68-74.
912. Gonzalez-Zulueta M, Shibata A,
Ohneseit PF, Spruck CH3rd, Busch C,
Shamaa M, el Baz M, Nichols PW,
Gonzalgo ML, Malmstrom PU, Jones PA
(1995). High frequency of chromosome 9p
allelic loss and CDKN2 tumor suppressor
gene alterations in squamous cell carcinoma
of the bladder. J Natl Cancer Inst
87: 1383-1393.
913. Goodman JD, Carr L, Ostrovsky PD,
Sunshine R, Yeh HC, Cohen EL (1985).
Testicular lymphoma: sonographic findings.
Urol Radiol 7: 25-27.
914. Gorgoulis VG, Barbatis C, Poulias I,
Karameris AM (1995). Molecular and
immunohistochemical evaluation of epidermal
growth factor receptor and c-erb-
B-2 gene product in transitional cell carcinomas
of the urinary bladder: a study in
Greek patients. Mod Pathol 8: 758-764.
915. Goto K, Konomoto T, Hayashi K,
Kinukawa N, Naito S, Kumazawa J,
Tsuneyoshi M (1997). p53 mutations in
multiple urothelial carcinomas: a molecular
analysis of the development of multiple
carcinomas. Mod Pathol 10: 428-437.
916. Govender D, Nteene LM, Chetty R,
Hadley GP (2001). Mature renal teratoma
and a synchronous malignant neuroepithelial
tumour of the ipsilateral adrenal gland.
J Clin Pathol 54: 253-254.
917. Govender D, Sabaratnam RM, Essa AS
(2002). Clear cell ‘sugar’ tumor of the
breast: another extrapulmonary site and
review of the literature. Am J Surg Pathol
26: 670-675.
918. Gown AM, Vogel AM (1984).
Monoclonal antibodies to human intermediate
filament proteins. II. Distribution of
filament proteins in normal human tissues.
Am J Pathol 114: 309-321.
919. Goyanna R, Emmet JL, McDonald JR
(1951). Exstrophy of the bladder complicated
by adenocarcinoma. J Urol 65: 391-400.
920. Grabstald H (1973). Proceedings:
Tumors of the urethra in men and women.
Cancer 32: 1236-1255.
921. Grabstald H (1984). Prostatic biopsy in
selected patients with carcinoma in situ of
the bladder: preliminary report. J Urol 132:
1117-1118.
922. Grabstald H, Whitmore WF, Melamed
MR (1971). Renal pelvic tumors. JAMA 218:
845-854.
923. Grace DA, Winter CC (1968). Mixed differentiation
of primary carcinoma of the
urinary bladder. Cancer 21: 1239-1243.
924. Grady RW, Ross JH, Kay R (1997).
Epidemiological features of testicular teratoma
in a prepubertal population. J Urol
158: 1191-1192.
925. Grammatico D, Grignon DJ, Eberwein
P, Shepherd RR, Hearn SA, Walton JC
(1993). Transitional cell carcinoma of the
renal pelvis with choriocarcinomatous differentiation.
Immunohistochemical and
immunoelectron microscopic assessment
of human chorionic gonadotropin production
by transitional cell carcinoma of the
urinary bladder. Cancer 71: 1835-1841.
926. Granter SR, Fletcher JA, Renshaw AA
(1997). Cytologic and cytogenetic analysis
of metanephric adenoma of the kidney: a
report of two cases. Am J Clin Pathol 108:
544-549.
927. Grantham JG, Charboneau JW, James
EM, Kirschling RJ, Kvols LK, Segura JW,
Wold LE (1985). Testicular neoplasms: 29
tumors studied by high-resolution US.
Radiology 157: 775-780.
928. Grasso M, Blanco S, Franzoso F, Lania
C, di Bella C, Crippa S (2002). Solitary
fibrous tumor of the prostate. J Urol 168:
1100.
929. Gravas S, Papadimitriou K, Kyriakidis
A (1999). Sclerosing sertoli cell tumor of
the testis—a case report and review of the
literature. Scand J Urol Nephrol 33: 197-
199.
930. Gravholt CH, Fedder J, Naeraa RW,
Muller J (2000). Occurrence of gonadoblastoma
in females with Turner syndrome
and Y chromosome material: a population
study. J Clin Endocrinol Metab 85: 3199-
3202.
931. Gray GFJr, Marshall VF (1975).
Squamous carcinoma of the prostate. J
Urol 113: 736-738.
932. Greco MA, Feiner HD, Theil KS,
Mufarrij AA (1984). Testicular stromal
tumor with myofilaments: ultrastructural
comparison with normal gonadal stroma.
Hum Pathol 15: 238-243.
933. Green AJ, Sepp T, Yates JR (1996).
Clonality of tuberous sclerosis harmatomas
shown by non-random X-chromosome
inactivation. Hum Genet 97: 240-
243.
934. Green DM, Beckwith JB, Breslow NE,
Faria P, Moksness J, Finklestein JZ,
Grundy P, Thomas PR, Kim T, Shochat S,
Haase G, Ritchey ML, Kelalis PP, Dangio
GJ (1994). Treatment of children with
stages II to IV anaplastic Wilms’ tumor: a
report from the National Wilms’ Tumor
Study Group. J Clin Oncol 12: 2126-2131.
935. Green DM, Breslow NE, Beckwith JB,
Moksness J, Finklestein JZ, D’Angio GJ
(1994). Treatment of children with clearcell
sarcoma of the kidney: a report from
the National Wilms’ Tumor Study Group. J
Clin Oncol 12: 2132-2137.
936. Green DM, Breslow NE, Beckwith JB,
Norkool P (1993). Screening of children
with hemihypertrophy, aniridia, and
Beckwith-Wiedemann syndrome in
patients with Wilms tumor: a report from
the National Wilms Tumor Study. Med
Pediatr Oncol 21: 188-192.
937. Green GA, Hanlon AL, Al Saleem T,
Hanks GE (1998). A Gleason score of 7 predicts
a worse outcome for prostate carcinoma
patients treated with radiotherapy.
Cancer 83: 971-976.
938. Green LF, Farrow GM, Ravits JM
(1979). Prostatic adenocarcinoma of ductal
origin. J Urol 121: 303-305.
939. Green R, Epstein JI (1999). Use of
intervening unstained slides for immunohistochemical
stains for high molecular
weight cytokeratin on prostate needle
biopsies. Am J Surg Pathol 23: 567-570.
940. Greene DR, Wheeler TM, Egawa S,
Dunn JK, Scardino PT (1991). A comparison
of the morphological features of cancer
arising in the transition zone and in the
peripheral zone of the prostate. J Urol 146:
1069-1076.
941. Greene DR, Wheeler TM, Egawa S,
Weaver RP, Scardino PT (1991).
Relationship between clinical stage and
histological zone of origin in early prostate
cancer: morphometric analysis. Br J Urol
68: 499-509.
942. Greene LF, Mulcahy JJ, Warren MM,
Dockerty MB (1973). Primary transitional
cell carcinoma of the prostate. J Urol 110:
235-237.
943. Greene LF, O’Dea MJ, Dockerty MB
(1976). Primary transitional cell carcinoma
of the prostate. J Urol 116: 761-763.
944. Greene LF, Page DL, Fleming D, Firtz A,
Batch M, Haller DG, Morrow M (2002).
American Joint Committee on Cancer
(AJCC) Cancer Staging Manual. 6 th Edition.
Springer-Verlag: New York.
945. Gregoire L, Cubilla AL, Reuter VE, Haas
GP, Lancaster WD (1995). Preferential
association of human papillomavirus with
high-grade histologic variants of penileinvasive
squamous cell carcinoma. J Natl
Cancer Inst 87: 1705-1709.
946. Griebling TL, Ozkutlu D, See WA,
Cohen MB (1997). Prognostic implications
of extracapsular extension of lymph node
metastases in prostate cancer. Mod
Pathol 10: 804-809.
947. Griffin JH, Waters WB (1996). Primary
leiomyosarcoma of the ureter. J Surg
Oncol 62: 148-152.
948. Grignon DJ (1997). Neoplasms of the
urinary bladder. In: Urologic Surgical
Pathology, DG Bostwick, JN Eble, eds.
Mosby: St Louis, pp. 269-270.
949. Grignon DJ, Ayala AG, el-Naggar A,
Wishnow KI, Ro JY, Swanson DA,
McLemore D, Giacco GG, Guinee VF (1989).
Renal cell carcinoma. A clinicopathologic
and DNA flow cytometric analysis of 103
cases. Cancer 64: 2133-2140.
950. Grignon DJ, Ayala AG, Ro JY, el-
Naggar A, Papadopoulos NJ (1990).
Primary sarcomas of the kidney. A clinicopathologic
and DNA flow cytometric study
of 17 cases. Cancer 65: 1611-1618.
951. Grignon DJ, Eble JN (1998). Papillary
and metanephric adenomas of the kidney.
Semin Diagn Pathol 15: 41-53.
952. Grignon DJ, Ro JY, Ayala AG, Johnson
DE (1991). Primary signet-ring cell carcinoma
of the urinary bladder. Am J Clin Pathol
95: 13-20.
953. Grignon DJ, Ro JY, Ayala AG, Johnson
DE, Ordonez NG (1991). Primary adenocarcinoma
of the urinary bladder. A clinicopathologic
analysis of 72 cases. Cancer 67:
2165-2172.
954. Grignon DJ, Ro JY, Ordonez NG, Ayala
AG, Cleary KR (1988). Basal cell hyperplasia,
adenoid basal cell tumor, and adenoid
cystic carcinoma of the prostate gland: an
immunohistochemical study. Hum Pathol
19: 1425-1433.
955. Groeneveld AE, Marszalek WW,
Heyns CF (1996). Bladder cancer in various
population groups in the greater Durban
area of KwaZulu-Natal, South Africa. Br J
Urol 78: 205-208.
956. Groisman GM, Dische MR, Fine EM,
Unger PD (1993). Juvenile granulosa cell
tumor of the testis: a comparative immunohistochemical
study with normal infantile
gonads. Pediatr Pathol 13: 389-400.
957. Gronau S, Menz CK, Melzner I,
Hautmann R, Moller P, Barth TF (2002).
Immunohistomorphologic and molecular
cytogenetic analysis of a carcinosarcoma
of the urinary bladder. Virchows Arch 440:
436-440.
958. Gronwald J, Storkel S, Holtgreve-Grez
H, Hadaczek P, Brinkschmidt C, Jauch A,
Lubinski J, Cremer T (1997). Comparison of
DNA gains and losses in primary renal
clear cell carcinomas and metastatic sites:
importance of 1q and 3p copy number
changes in metastatic events. Cancer Res
57: 481-487.
959. Grosfeld JL (1999). Risk-based management:
current concepts of treating
malignant solid tumors of childhood. J Am
Coll Surg 189: 407-425.
960. Grossfeld GD, Ginsberg DA, Stein JP,
Bochner BH, Esrig D, Groshen S, Dunn M,
Nichols PW, Taylor CR, Skinner DG, Cote
RJ (1997). Thrombospondin-1 expression in
bladder cancer: association with p53 alterations,
tumor angiogenesis, and tumor progression.
J Natl Cancer Inst 89: 219-227.
961. Grossfeld GD, Shi SR, Ginsberg DA,
Rich KA, Skinner DG, Taylor CR, Cote RJ
(1996). Immunohistochemical detection of
thrombospondin-1 in formalin-fixed, paraffin-embedded
tissue. J Histochem
Cytochem 44: 761-766.
962. Grossman E, Messerli FH, Boyko V,
Goldbourt U (2002). Is there an association
between hypertension and cancer mortality?
Am J Med 112: 479-486.
963. Grossman HB, Liebert M, Antelo M,
Dinney CP, Hu SX, Palmer JL, Benedict WF
(1998). p53 and RB expression predict progression
in T1 bladder cancer. Clin Cancer
Res 4: 829-834.
964. Grossman HB, Schmitz-Drager B,
Fradet Y, Tribukait B (2000). Use of markers
in defining urothelial premalignant and
malignant conditions. Scand J Urol
Nephrol Suppl 205: 94-104.
965. Grubb GR, Yun K, Williams BR, Eccles
MR, Reeve AE (1994). Expression of WT1
protein in fetal kidneys and Wilms tumors.
Lab Invest 71: 472-479.
320 References